Staphyt’s Post

💡 Want to stay ahead of the curve? Follow our experts! At Staphyt, our teams are constantly monitoring the latest regulatory shifts, field methodologies, and scientific innovations to help you navigate the agricultural market with confidence. Our experts frequently share their deep industry knowledge, real-time trial updates, and compliance tips right here on LinkedIn. If you want to make sure you never miss a critical industry update, make sure you are following them! Check out this breaking news by our expert, Jeanne Millan Bernal, below. 👇 Want more insights like this? Hit the follow button on Jeanne's profile to keep your feed sharp and informed! #Staphyt #Agroscience #IndustryExperts #RegulatoryAffairs #Agronomy #CropProtection #Innovation #ContinuousLearning

On 19 May, you may have noticed in our PPP & PNP Regulatory overview that the list of unacceptable co-formulants was updated on 1 April; and in a previous breaking news, that the Regulation (EU) 2026/1120 had been implemented on 26 May. Last 26 June, ANSES released a note on how to implement the new Regulation in France. For authorisation requests submitted before 16/06/2026, and currently under instruction, requests for non-significant changes in composition must be submitted as soon as possible and no later than 16/12/2026. And more urgently, no later than 31/07/2026, holders of plant protection products, adjuvants, and mixed products containing one or more co-formulants newly added to Annex III are invited to declare them to ANSES via email. Our team in Staphyt will be happy to guide you and support you in the preparation of your dossiers. As a reminder, these new forbidden co-formulants are: Acetaldehyde  Propylene oxide  Cumene Dodecamethylcyclohexasiloxane; (D6)  Decamethylcyclopentasiloxane; (D5)  Octamethylcyclotetrasiloxane; (D4)  2-(2'-hydroxy-3'-tert-buty-5'- methylphenyl)-5-chlorobenzotriazole Distillates (petroleum) solvent-dewaxed light paraffinic with a content of ≥ 3,0 % DMSO-extract (measured by IP 346)  3,5,7-Triaza-1-azoniatricyclo[3.3.1.1 3,7] decane,1-(3-chloro-2-propen-1-yl)-, chloride  Phosphinic acid, bis(perfluoroC6-12-alkyl) derivatives 1,4-dioxane  2-(4-tert-butylbenzyl)propionaldehyde  Would you be struggling to find suitable alternatives to these compounds, we can also support this aspect thanks to Staphyt collaboration with Stepan, Advanced Formulation Service. We are here to help ! #Staphyt #PPP #coformulants #ANSES Romain Galy Geoffroy Moulin Elena Campagnoli Asha Hoque Evelyne Güsken

To view or add a comment, sign in

Explore content categories